In summary, our results clearly establish that the levels of IL-13Rα2 gene expression play an important role in ACC pathogenesis and may serve as a prognostic biomarker of disease progression and adverse outcome in these patients. This evidence concerns the gene IL13RA2 and adrenal cortex carcinoma.